# pathway_0083

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **B** — Antifungal biosynthesis. .

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | valid_review |

**Paired comparison:** key agree; reasoning agree. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MDLTTTSHARVDSGGVPFTSSLNDPTPPKLSASIALPAHLHLLAKAYGIPESHILQLAWALAANEQNARTAQWEHLELDERQAISWVLRHWQDPSVHRYLSPDELRGDKHQIPATVMAVVEEYSLFQTLALTGSETEIGMCFHPSTEQPWLRVIWNPEGMLASSASRLTRALESALHAVFLTPHVKVGDLTLFSIWDHQQILQWNSHYPQATDRLVHELFKDVVDASPQANAVAAWDGELTYRELDRLSSRLSGRLQDEFGVQPETIVVLCFEKSVWAIVAMLAVVKAGGAFLHVDPQHPAVRHQAMVQTTAAKLVLCSARTRSIISASVPECTSLVIDRRAFSVEPDHVQHETLLSSQNLSPRNAAYVVCTSGSTGTPKAIVVEHASLSTSVDAQANAMEISSGSRVLQYAAYTFDVSVGDIFTALTHGACICIPSDWERSHDLAGAINRLNVNQACLTSTVASILSPAEVPGLEKLTLGGEPATRQCVDAWAEQVRLKNVYGPAECTVWCMIQPEVSRHISVSNIGHGIGARAWIVHPEDHDRLMPVGAVGELLIEGPLVARGYLNDSTRTDEVFLSQPPRWLESFGPTPSRSRFYKTGDLARYGPAGALLFEGRKDTQIKLRGQRIELSEIEYRLHRALSDQVATAVELAHPKGSTAPVLAAFITWDQGIDLQNVQNVTLDARQEFEELASRIKAEIEQALPSYMVPALFIPVQTLPLTTSGKLDRKSLRHFCSQCSHEFLKKLDDSSPADAAPKESANPAEENLARLWAQVLERKSESIRRGDNFLSLGGDSLAAMRLVNLAARDLRLTLTVADVFNSPILADQANLLRPLVQTKHIAPFELVTDGDLPIQDLMDSVAKQCGLTSDQVEDVYPCTPYQEEMVRDSLSGTRTQMGQEVIQLASDLDLSRYLSACARVFQRCPILRTRFVEISGKLLQVVIREDISWQRPTSLAAYIEADNQTPPTLGKPLARWALTEDSTHLVLTMHHAIFDGISLGQIFGAIYAVYQSIPLPQVNLTFATFIGKIYRPHHDLPDASKQFWRSYLSPTAGSNDAPLSDVERASRPCANSGTQRLVTFQAGAVKALQQHGLTEATLARAAWACTLARGRQSPDSDVIFGTILTGRNIHLPGVDALAAPALAHTPIRVRMAAAQQEKPAHFLARVQADATAMIPFEHDGMDRIRALDEQVRVACDNMRTLLVIQPIPEGLILDSKSPFPGTMLSGPRVEAREMRHFHWYGLLMECTLLPMDGFFVRMSFDDTLYSPEAAERLLDEYSQTLHELAHGLTVDGSTE

[Multiple Choices]
A. L-threonine from L-aspartate: step 5/5. .
B. Antifungal biosynthesis. .
C. ergot alkaloid biosynthesis. .
D. oxylipin biosynthesis. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here.

Citations as saved: [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3), [C5](#evidence-c5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.


**Missing item-specific fact**

> The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.


**Reason**

> Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence.


### Important caveats

- The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.
- Reviewer-only accession and pathway information were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.",
    "reason": "Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input."
  },
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "evidence_ids": [
      "H1",
      "H2",
      "H3",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.",
    "Reviewer-only accession and pathway information were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt entry for nonribosomal peptide synthetase ResC, annotated to the antifungal biosynthesis pathway. The historical entry attributes that pathway annotation to experimental evidence from a cited publication, though the primary paper was not independently assessed here.",
    "evidence_ids": ["H1", "H2", "H3", "C5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The long sequence is consistent with a large nonribosomal peptide synthetase, supporting a role in fungal secondary metabolism and making the ordinary amino-acid biosynthesis and oxylipin choices less fitting. That general clue does not establish which specific secondary-metabolite pathway it serves.",
    "missing_item_specific_fact": "The protein-specific annotation that ResC belongs to the restricticin biosynthetic cluster and is assigned to antifungal biosynthesis.",
    "reason": "Distinguishing antifungal biosynthesis from another fungal specialized-metabolite pathway requires knowing this protein's particular cluster or pathway assignment; that information is absent from the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "From the sequence and choices alone, a fungal nonribosomal peptide synthetase is compatible with specialized-metabolite biosynthesis, but the input does not distinguish antifungal biosynthesis from ergot alkaloid biosynthesis. The external annotation supports B for this exact sequence."
  },
  "important_caveats": [
    "The source annotation is sequence-matched and cites experimental evidence, but the primary publication was not independently reviewed.",
    "Reviewer-only accession and pathway information were not provided to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2), [C4](#evidence-c4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.


**Missing item-specific fact**

> The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.


**Reason**

> While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous.


### Important caveats

- The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.
- The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.
- The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.",
    "reason": "While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup."
  },
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2",
      "C4"
    ],
    "judgment": "supported",
    "reason": "UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported."
  },
  "important_caveats": [
    "The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.",
    "The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0083",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry P0DXV3 (RESC_ASPSL, Nonribosomal peptide synthetase resC / Restricticin biosynthesis cluster protein C) carries the PATHWAY annotation 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence from PubMed:39105744, a 2024 J. Agric. Food Chem. paper confirming function, catalytic activity, and pathway). The sequence matches exactly (SHA-256 confirmed). The expected answer B is directly and experimentally supported.",
    "evidence_ids": ["C5", "C6", "H3", "H2", "C4"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A knowledgeable model could identify the protein as a nonribosomal peptide synthetase (NRPS) from domain signatures (condensation, adenylation, and thiolation motifs visible in the ~1295-aa sequence), which eliminates options A (threonine synthase) and D (oxylipin/lipoxygenase pathway) since those involve entirely different enzyme classes. However, distinguishing B (Antifungal biosynthesis) from C (ergot alkaloid biosynthesis) requires knowing which specific secondary metabolite this particular NRPS assembles. Both are fungal NRPS-associated pathways, and the sequence does not contain a generalizable signature that uniquely maps to 'antifungal' rather than 'ergot alkaloid' biosynthesis.",
    "missing_item_specific_fact": "The identity of the compound synthesized by this specific NRPS (restricticin) and its classification as an antifungal agent. This requires either exact sequence-to-database matching (UniProt P0DXV3) or memorization of the restricticin biosynthetic cluster literature (PubMed:39105744). Without this item-specific annotation, the B-vs-C distinction cannot be resolved by general biological reasoning about NRPS enzymes.",
    "reason": "While NRPS identification from domain architecture is feasible, the pathway assignment among plausible fungal secondary-metabolite options (B vs C) depends on knowing the specific biosynthetic product. No general NRPS feature distinguishes antifungal peptide biosynthesis from ergot alkaloid biosynthesis at the sequence level without database lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D are clearly eliminable for an NRPS enzyme. Between B and C, the UniProt annotation with experimental evidence definitively assigns 'Antifungal biosynthesis.' Ergot alkaloid biosynthesis involves a different NRPS (EasC) with distinct substrate specificity and is not applicable to this restricticin-cluster protein. Although a model lacking database access might struggle to distinguish B from C, the annotation is unambiguous."
  },
  "important_caveats": [
    "The UniProt entry was first released in 2025-02-05 (entry version 1) and the pathway annotation was added with experimental evidence from a 2024 publication. The benchmark construction date relative to this entry's availability is unknown.",
    "The 'Antifungal biosynthesis' pathway label is a UniProt-curated category; the underlying compound (restricticin) is described in the source paper as having 'phytotoxic activity,' and the antifungal classification comes from the UniProt curation team's pathway assignment.",
    "The sequence is 1295 aa, consistent with a single-module NRPS (C-A-T architecture), which is a necessary but not sufficient clue for pathway identification."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `P0DXV3` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 4. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:45.732991+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39105744","source":"PubMed"}],"value":"Restricticin biosynthesis cluster protein C"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"39105744","source":"PubMed"}],"value":"6.3.2.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"39105744","source":"PubMed"}],"value":"Nonribosomal peptide synthetase resC"}}}
```

Source SHA-256: `19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)  
**Locator:** `/comments/3`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:45.732991+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39105744","source":"PubMed"}],"value":"Antifungal biosynthesis"}]}
```

Source SHA-256: `19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV3.json)  
**Locator:** `/references/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:45.732991+00:00.  

```json
{"citation":{"authors":["Lu Y.","Li Y.","Dou M.","Liu D.","Lin W.","Fan A."],"citationCrossReferences":[{"database":"PubMed","id":"39105744"},{"database":"DOI","id":"10.1021/acs.jafc.4c04244"}],"citationType":"journal article","firstPage":"18520","id":"39105744","journal":"J. Agric. Food Chem.","lastPage":"18527","publicationDate":"2024","title":"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.","volume":"72"},"referenceNumber":1,"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC DNA]","FUNCTION","CATALYTIC ACTIVITY","PATHWAY"]}
```

Source SHA-256: `19a0760299ea86767aedd0c4bc7a4c03cea71f9b30a199fbad0f1273b220873a`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)  
**Locator:** `lines 1-14`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:53.747402+00:00.  

```text
ID   RESC_ASPSL              Reviewed;        1295 AA.
AC   P0DXV3;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2025, sequence version 1.
DT   28-JAN-2026, entry version 4.
DE   RecName: Full=Nonribosomal peptide synthetase resC {ECO:0000303|PubMed:39105744};
DE            EC=6.3.2.- {ECO:0000305|PubMed:39105744};
DE   AltName: Full=Restricticin biosynthesis cluster protein C {ECO:0000303|PubMed:39105744};
GN   Name=resC {ECO:0000303|PubMed:39105744};
OS   Aspergillus sclerotiorum.
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=138282;
```

Source SHA-256: `1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)  
**Locator:** `lines 15-22`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:53.747402+00:00.  

```text
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;
RA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;
RT   "Discovery of a hybrid molecule with phytotoxic activity by genome mining,
RT   heterologous expression, and OSMAC strategy.";
RL   J. Agric. Food Chem. 72:18520-18527(2024).
```

Source SHA-256: `1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV3?format=txt&versions=4)  
**Locator:** `lines 52-52`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:53.747402+00:00.  

```text
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.
```

Source SHA-256: `1b7003df6665300ef1ac888ec6d64f0457b8f53c5d0454d1efab44d4b6ba307d`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 83. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
